Symbol="NRBO"
AssetType="Common Stock"
Name="Neurobo Pharmaceuticals Inc"
Description="NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company, provides therapies for coronavirus neurodegenerative and cardiometabolic diseases. The company is headquartered in Boston, Massachusetts."
CIK="1638287"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="P.O. BOX 130235, ANN ARBOR, MI, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="16125400"
EBITDA="-11054000"
PERatio="None"
PEGRatio="None"
BookValue="0.755"
DividendPerShare="0"
DividendYield="0"
EPS="-14.36"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.308"
ReturnOnEquityTTM="-0.845"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-14.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.84"
EVToRevenue="-"
EVToEBITDA="-0.333"
Beta="-0.808"
num_52WeekHigh="29.9"
num_52WeekLow="0.361"
num_50DayMovingAverage="0.504"
num_200DayMovingAverage="2.102"
SharesOutstanding="27241700"
DividendDate="2019-12-31"
ExDividendDate="None"
symbol="NRBO"
open="0.45"
high="0.53"
low="0.44"
price="0.51"
volume="1192309.00"
latest_trading_day="2023-07-18"
previous_close="0.44"
change="0.07"
change_percent="16.2255%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="80"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="20"
Volume_recent_avg="454500"
Change_recent_avg="0.01"
Delta_recent_avg="0.05"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-0.78"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_45"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="20"
Aroon_momentum_negative="80"
image_negative_thumbnail_id_1="164"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0012.jpeg"
image_negative_thumbnail_id_2="1146"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0179.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="567"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_positive_thumbnail_id_1="964"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0126.jpeg"
image_positive_thumbnail_id_2="975"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
